Xtl Biopharma ADR (XTLB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2019 | 12-2018 | 12-2017 | 12-2016 | 12-2015 | |
| Operating Expenses | 842 | 793 | 1,246 | 2,561 | 3,611 |
| Operating Income | -842 | -793 | -1,246 | -2,561 | -3,611 |
| Interest Expense | 29 | 35 | 8 | 7 | 15 |
| Other Income | -476 | 3,814 | 473 | 23 | 4 |
| Pre-tax Income | -1,347 | 2,986 | -781 | -2,545 | -3,622 |
| Net Income Continuous | -1,347 | 2,986 | -781 | -2,545 | -3,622 |
| Net Income Discontinuous | N/A | N/A | N/A | N/A | -689 |
| Minority Interests | N/A | N/A | N/A | N/A | 2 |
| Net Income | $-1,347 | $2,986 | $-781 | $-2,545 | $-4,313 |
| EPS Basic Total Ops | -0.30 | 0.60 | -0.20 | -0.90 | -0.33 |
| EPS Basic Continuous Ops | -0.26 | 0.58 | -0.17 | -0.93 | -0.27 |
| EPS Basic Discontinuous Ops | N/A | N/A | N/A | N/A | -0.05 |
| EPS Diluted Total Ops | -0.30 | 0.60 | -0.20 | -0.90 | -0.33 |
| EPS Diluted Continuous Ops | -0.26 | 0.58 | -0.17 | -0.93 | -0.27 |
| EPS Diluted Discontinuous Ops | N/A | N/A | N/A | N/A | -0.05 |
| EPS Diluted Before Non-Recurring Items | -0.30 | N/A | N/A | N/A | N/A |
| EBITDA(a) | $-842 | $-793 | $-1,246 | $-1,710 | $-2,000 |